Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 6/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10041284 | 0.86 | MAPK1 (0.53) | GSRMAPK1ALDH1A1KDM4EHPGD | |
| SCHEMBL10041274 | 0.85 | MAPK1 (0.43) | GSRMAPK1ALDH1A1KDM4EHPGD | |
| SCHEMBL10041258 | 0.83 | MAPK1 (0.49) | GSRMAPK1ALDH1A1KDM4EADORA2A | |
| SCHEMBL12026134 | 0.80 | MAPK1 (0.61) | GSRMAPK1ALDH1A1HTTTSHR | |
| SCHEMBL26375547 | 0.79 | HTT (0.61) | GSRMAPK1ALDH1A1PIK3CBHTT | |
| SCHEMBL22298452 | 0.79 | GSR (0.52) | GSRMAPK1ALDH1A1ADORA2AHTT | |
| SCHEMBL10041280 | 0.79 | MAPK1 (0.41) | GSRMAPK1ALDH1A1KDM4EHPGD | |
| SCHEMBL63683 | 0.79 | SLC22A12 (0.46) | MAPK1ALDH1A1KDM4EADORA2AHTT | |
| SCHEMBL10041275 | 0.79 | MAPK1 (0.42) | GSRMAPK1ALDH1A1KDM4EHPGD | |
| SCHEMBL10041281 | 0.78 | MAPK1 (0.48) | GSRMAPK1ALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8147987-B2 | Organic electroluminescent element and compounds for use in the element | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8147987-B2 | Organic electroluminescent element and compounds for use in the element | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20070202357-A1 | Organic electroluminescent element and compounds for use in the element | FUJIFILM CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070202357-A1 | Organic electroluminescent element and compounds for use in the element | FUJIFILM CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070202357-A1 | Organic electroluminescent element and compounds for use in the element | RPL31, RPL38, RPL39 | GSR 2347/4885MAPK1 1465/4885ALDH1A1 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.